A longitudinal study of follow-up activities after curative treatment for head and neck cancer

References

• Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet 2003;362:933–40.
   PubMed Web of Science ®Google Scholar
• Manikantan K, Dwivedi RC, Sayed SI, Pathak KA, Kazi R. Current concepts of surveillance and its significance in head and neck cancer. Ann R Coll Surg Engl 2011;93:576–82.
   PubMed Web of Science ®Google Scholar
• Digonnet A, Hamoir M, Andry G, Haigentz M, Jr, Takes RP, Silver CE, et al. Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 2013;270:1569–80.
   PubMed Web of Science ®Google Scholar
• Pagh A, Vedtofte T, Lynggaard CD, Rubek N, Lonka M, Johansen J, et al. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA. Acta Oncol 2013;52:277–84.
   PubMed Web of Science ®Google Scholar
• Kothari P, Trinidade A, Hewitt RJ, Singh A, O’Flynn P. The follow-up of patients with head and neck cancer: An analysis of 1,039 patients. Eur Arch Otorhinolaryngol 2011;268:1191–200.
   PubMed Web of Science ®Google Scholar
• Agrawal A, deSilva BW, Buckley BM, Schuller DE. Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer. Laryngoscope 2004;114:232–5.
   PubMed Web of Science ®Google Scholar
• Mortensen HR, Overgaard J, Specht L, Overgaard M, Johansen J, Evensen JF, et al. Prevalence and peak incidence of acute and late normal tissue morbidity in the DAHANCA 6 & 7 randomised trial with accelerated radiotherapy for head and neck cancer. Radiother Oncol 2012;103: 69–75.
   PubMed Web of Science ®Google Scholar
• Hoff CM. Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Acta Oncol 2012;51:419–32.
   PubMed Web of Science ®Google Scholar
• Hoff CM, Grau C, Overgaard J. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma – a prospective study. Radiother Oncol 2012;103:38–44.
   PubMed Web of Science ®Google Scholar
• Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 1992;28:426–30.
   PubMed Web of Science ®Google Scholar
• Manikantan K, Khode S, Dwivedi RC, Palav R, Nutting CM, Rhys-Evans P, et al. Making sense of post-treatment surveillance in head and neck cancer: When and what of follow-up. Cancer Treat Rev 2009;35:744–53.
   PubMed Web of Science ®Google Scholar
• Lester SE, Wight RG. ‘When will I see you again?‘ Using local recurrence data to develop a regimen for routine surveillance in post-treatment head and neck cancer patients. Clin Otolaryngol 2009;34:546–51.
   PubMed Web of Science ®Google Scholar
• Ritoe SC, Krabbe PF, Kaanders JH, van dH, Verbeek AL, Marres HA. Value of routine follow-up for patients cured of laryngeal carcinoma. Cancer 2004;101:1382–9.
   PubMed Web of Science ®Google Scholar
• Schwartz DL, Barker J, Jr., Chansky K, Yueh B, Raminfar L, Drago P, et al. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma – too much for too little? Head Neck 2003;25:990–9.
   PubMed Web of Science ®Google Scholar
• Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol 2001;258:177–83.
   PubMed Web of Science ®Google Scholar
• O’Meara WP, Thiringer JK, Johnstone PA. Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol 2003;66:323–6.
   PubMed Web of Science ®Google Scholar
• Snow GB. Follow-up in patients treated for head and neck cancer: How frequent, how thorough and for how long? Eur J Cancer 1992;28:315–6.
   PubMed Web of Science ®Google Scholar
• Chera BS, Eisbruch A, Murphy BA, Ridge JA, Gavin P, Reeve BB, et al. Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. J Natl Cancer Inst 2014;106:10.1093/jnci/dju127.
   PubMedGoogle Scholar
• de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg 1994;120:934–9.
   PubMedGoogle Scholar
• Nisa L, La Macchia R, Boujelbene N, Sandu K, Khanfir K, Giger R. Correlation between subjective evaluation of symptoms and objective findings in early recurrent head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg 2013;139:687–93.
   PubMed Web of Science ®Google Scholar
• Mukherji SK, Mancuso AA, Kotzur IM, Mendenhall WM, Kubilis PS, Tart RP, et al. Radiologic appearance of the irradiated larynx. Part II. Primary site response. Radiology 1994;193:149–54.
   PubMed Web of Science ®Google Scholar